IRIS PubliCatt

Bianco, Assunta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.269
NA - Nord America 1.207
AS - Asia 341
AF - Africa 15
SA - Sud America 6
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.845
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.200
DE - Germania 489
SE - Svezia 286
CN - Cina 149
IT - Italia 119
UA - Ucraina 83
FR - Francia 69
IE - Irlanda 66
SG - Singapore 66
GB - Regno Unito 58
ID - Indonesia 46
IN - India 40
FI - Finlandia 25
RU - Federazione Russa 24
BE - Belgio 15
TR - Turchia 15
CI - Costa d'Avorio 13
IR - Iran 8
CA - Canada 7
AT - Austria 5
PL - Polonia 5
IL - Israele 4
JP - Giappone 4
VN - Vietnam 4
AU - Australia 3
BR - Brasile 3
NL - Olanda 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
ES - Italia 2
HR - Croazia 2
HU - Ungheria 2
KR - Corea 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
AR - Argentina 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
KE - Kenya 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
Totale 2.845
Salva come PNG Salva come JPEG
Città #
Chandler 328
Ashburn 89
Ann Arbor 71
Dublin 66
San Mateo 59
Jacksonville 57
Nürnberg 51
Jakarta 46
New York 46
Singapore 41
Nanjing 28
Wilmington 28
Boston 27
Princeton 25
Beijing 24
Woodbridge 24
Milan 23
Dearborn 22
Moscow 19
Bremen 18
Marseille 18
Brussels 15
Pune 15
Rome 15
Izmir 14
Abidjan 13
Houston 13
Los Angeles 12
Norwalk 11
Cattolica 10
Chicago 10
Lawrence 10
Redwood City 9
Seattle 9
Helsinki 8
Leawood 8
Munich 8
Boardman 7
Hefei 7
Kunming 7
Nanchang 7
Andover 6
Detroit 6
Mountain View 5
Rovato 5
Shenyang 5
Tianjin 5
University Park 5
Edinburgh 4
Fairfield 4
Fremont 4
Hanoi 4
Hebei 4
Jiaxing 4
Redmond 4
Shanghai 4
Ardabil 3
Atlanta 3
Augusta 3
Changsha 3
Fuzhou 3
Guangzhou 3
Hangzhou 3
Nibionno 3
Ottawa 3
Septeme 3
Toronto 3
A Coruña 2
Bucharest 2
Budapest 2
Catania 2
Changchun 2
Chengdu 2
Chiswick 2
Clearwater 2
Costa Mesa 2
Duncan 2
Florence 2
Hamilton 2
Indiana 2
Landolfshausen 2
Lappeenranta 2
Lodz 2
London 2
Lviv 2
Melbourne 2
Ningbo 2
Oxford 2
Pesaro 2
Prilep 2
Provo 2
Seoul 2
Tubas 2
Vienna 2
Viterbo 2
Washington 2
Zurich 2
Amsterdam 1
Asciano 1
Auburn Hills 1
Totale 1.483
Salva come PNG Salva come JPEG
Nome #
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 209
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 194
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 158
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 152
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 134
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 124
Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral 117
Lambert-Eaton Myasthenic Syndrome associated with gastric schwannoma 115
Demyelinating Encephalomyeloradiculitis with Balò-like lesions 112
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 97
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 75
Glioblastoma in multiple sclerosis: a case report 74
Fingolimod vs dimethyl fumarate in multiple sclerosis 72
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 67
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 66
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 64
Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity 63
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 60
Acyclovir-related kidney injury during alemtuzumab infusion 54
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 54
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 52
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 50
Epidemiology of intensive care unit-acquired sepsis in Italy: Results of the SPIN-UTI network 49
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 48
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 48
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 46
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 44
The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray) 43
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies 43
Cyclophosphamide in highly aggressive Marburg-like multiple sclerosis 42
Moving to fingolimod from natalizumab in multiple sclerosis: the ENIGM is not solved 41
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report 40
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 40
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 39
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod 36
Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study 36
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study (Journal of Neurology, (2022), 269, 3, (1610-1617), 10.1007/s00415-021-10737-w) 26
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 23
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 22
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 20
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 14
A true isolated cognitive relapse in multiple sclerosis 12
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant? 9
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY) 8
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome 7
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study 3
Totale 2.902
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.367
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020289 0 0 19 10 29 46 30 4 32 25 72 22
2020/2021207 11 19 4 15 18 8 23 10 18 20 56 5
2021/2022391 35 16 19 41 13 11 9 61 23 23 54 86
2022/2023878 91 110 61 139 65 116 43 84 100 10 43 16
2023/2024408 19 94 14 21 16 69 35 14 7 20 44 55
2024/202596 14 25 57 0 0 0 0 0 0 0 0 0
Totale 2.902